Kymera Therapeutics
KYMR
KYMR
100 hedge funds and large institutions have $972M invested in Kymera Therapeutics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
50% less capital invested
Capital invested by funds: $1.93B → $972M (-$961M)
65% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 34
Holders
100
Holding in Top 10
3
Calls
$3.32M
Puts
–
Top Buyers
| 1 | +$35.6M | |
| 2 | +$28M | |
| 3 | +$26.2M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$10.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$9.75M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$27.6M | |
| 3 | -$15.6M | |
| 4 |
BlackRock
New York
|
-$11.6M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$9.61M |